A dexamethasone intracanalicular insert may provide a dropless treatment alternative for dry eye.

MYL-1701P, a biosimilar to aflibercept, had similar efficacy, safety and immunogenicity in diabetic macular edema.

Psoriasis was found to be an independent risk factor for developing neovascular AMD in diabetic patients.

While IV methylprednisolone led to greater decreases of TSH antibody in the first 3 months, levels did not differ from no treatment controls at 12 months.

A new study explores two-year efficacy & safety profiles of different anti-VEGF regimens for neovascular age-related macular degeneration.